###begin article-title 0
###xml 90 111 90 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 90 111 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Secretory Leukocyte Protease Inhibitor Is an Inducible Antimicrobial Peptide Expressed in Staphylococcus aureus Endophthalmitis
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Purpose</italic>
###xml 204 225 204 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 243 250 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 413 422 413 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 662 669 662 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 674 683 674 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1124 1135 1124 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions</italic>
###xml 1286 1295 1286 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 191 194 <span type="species:ncbi:10116">rat</span>
###xml 204 225 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 278 282 <span type="species:ncbi:10116">rats</span>
###xml 413 422 <span type="species:ncbi:1280">S. aureus</span>
###xml 674 683 <span type="species:ncbi:1280">S. aureus</span>
###xml 1272 1275 <span type="species:ncbi:10116">rat</span>
###xml 1286 1295 <span type="species:ncbi:1280">S. aureus</span>
Purpose. To describe the presence of secretory leukocyte protease inhibitor (SLPI), a cationic peptide with antimicrobial and antiprotease activity, in the innate ocular immune reaction in a rat model of Staphylococcus aureus endophthalmitis. Methods. Seventy-five female Lewis rats were divided into three groups: the endophthalmitis group received an intravitreal injection of 65 colony-forming units of viable S. aureus, the vehicle-injected group received balanced sterile saline solution (BSS), and the control group was not injected. Eyes were enucleated at 24 and 48 hours and processed for immunohistochemical staining and Western blot studies for SLPI. Results. In S. aureus endophthalmitis eyes, there was strong immunostaining for SLPI in the retina and vitreous with associated neutrophilic infiltrates. At 48 hours, corneas also stained for SLPI. Western blots confirmed increased SLPI expression in all infected eyes. By immunohistochemical assays, SLPI was absent in the BSS and control eyes. The causative pathogen was identified in all samples from the endophthalmitis group by traditional culture methods. Conclusions. To our knowledge, this report is the first to demonstrate the presence of SLPI in the inflamed cornea, vitreous, and retina tissues of rat eyes with S. aureus endophthalmitis, suggesting that SLPI has an active role in the innate immunity of the eye. Release of SLPI by inflammatory cells in the anterior and posterior segments may contribute to the host defense response against infectious endophthalmitis.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 235 261 235 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus epidermidis</italic>
###xml 266 287 266 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 897 898 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 235 261 <span type="species:ncbi:1282">Staphylococcus epidermidis</span>
###xml 266 287 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Infectious endophthalmitis is a potentially devastating complication of intraocular surgery, most commonly cataract extraction [1, 2]. Within hours, tissue damage and consequent loss of vision result from the inflammatory process [2]. Staphylococcus epidermidis and Staphylococcus aureus have remained the most prevalent infectious agents in postoperative bacterial endophthalmitis [3]. Early diagnosis and prompt treatment are essential to allay the host inflammatory response [1]. Specific and nonspecific defense mechanisms play an important role in ocular immunity, maintaining a delicate balance between effective defenses and potentially harmful inflammation responses [4]. Antimicrobial peptides contribute to innate immune defense against a number of Gram positive and Gram negative bacteria, viruses, and fungi [5]. These peptides include secretory leukocyte protease inhibitor (SLPI) [6-8], a cationic peptide, as well as defensins and cathelicidins.
###end p 4
###begin p 5
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human SLPI is an 11.7 kDa nonglycosylated protein initially isolated from respiratory mucosal epithelial cells [8]. It is composed of two domains: a protease inhibitor at the carboxyl-terminal domain and the antimicrobial amino-terminal domain [8-10]. SLPI has defensin-like antibacterial activities and suppresses the production of inflammatory mediators [9]. Recent studies demonstrate that macrophages secrete SLPI in response to bacterial lipopolysaccharides and toxins; therefore, we assume that SLPI modulates the ocular immune response in endophthalmitis [11, 12].
###end p 5
###begin p 6
###xml 214 220 <span type="species:ncbi:10090">murine</span>
To determine whether SLPI has a role in inflammation and infection of the eye, where SLPI has not been described before, we investigated and quantified SLPI expression in normal and infected ocular tissues using a murine bacterial endophthalmitis model.
###end p 6
###begin title 7
2. MATERIALS AND METHODS
###end title 7
###begin title 8
2.1. Experimental design
###end title 8
###begin p 9
Animals were handled in compliance with the tenets of the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in Ophthalmic and Vision Research and the Guide for the Care and Use of Laboratory Animals (National Research Council). All experiments were approved by the Institutional Animal Care Committee of the Catholic University of Cordoba, Argentina.
###end p 9
###begin p 10
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 246 255 246 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 322 331 322 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 474 483 474 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 26 30 <span type="species:ncbi:10116">rats</span>
###xml 96 105 <span type="species:ncbi:1280">S. aureus</span>
###xml 127 131 <span type="species:ncbi:10116">rats</span>
###xml 169 173 <span type="species:ncbi:10116">rats</span>
###xml 218 222 <span type="species:ncbi:10116">rats</span>
###xml 246 255 <span type="species:ncbi:1280">S. aureus</span>
###xml 281 285 <span type="species:ncbi:10116">rats</span>
###xml 322 331 <span type="species:ncbi:1280">S. aureus</span>
###xml 422 426 <span type="species:ncbi:10116">rats</span>
###xml 462 466 <span type="species:ncbi:10116">rats</span>
###xml 474 483 <span type="species:ncbi:1280">S. aureus</span>
###xml 493 497 <span type="species:ncbi:10116">rats</span>
###xml 551 555 <span type="species:ncbi:10116">rats</span>
###xml 591 595 <span type="species:ncbi:10116">rats</span>
###xml 639 643 <span type="species:ncbi:10116">rats</span>
###xml 707 711 <span type="species:ncbi:10116">rats</span>
###xml 750 754 <span type="species:ncbi:10116">rats</span>
###xml 793 797 <span type="species:ncbi:10116">rats</span>
###xml 829 833 <span type="species:ncbi:10116">rats</span>
Seventy-five female Lewis rats, each weighing 250 g, were divided amongst three groups: (1) the S. aureus inoculated group (30 rats), (2) the vehicle-injected group (30 rats), and (3) the un-injected control group (10 rats). The right eye of the S. aureus and the vehicle-injected rats received intravitreal injections of S. aureus inoculum and balanced salt solution (BSS), respectively; the left eye was uninjected. The rats were divided as follows: of the 30 rats in the S. aureus group, 8 rats were assigned to immunohistochemistry at 24 hours, 7 rats to Western blotting at 24 hours, 8 rats to immunohistochemistry at 48 hours, and 7 rats to Western blotting at 48 hours. The same was done with the 30 rats in the vehicle-injected group. The 10 rats without injection were divided into 5 rats for immunohistochemistry and 5 rats for Western blotting.
###end p 10
###begin p 11
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 225 227 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 426 435 425 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 476 478 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 622 631 620 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 657 666 655 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 714 716 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 730 739 727 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 818 820 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 235 238 <span type="species:ncbi:10116">rat</span>
###xml 426 435 <span type="species:ncbi:1280">S. aureus</span>
###xml 465 469 <span type="species:ncbi:10116">rats</span>
###xml 622 631 <span type="species:ncbi:1280">S. aureus</span>
###xml 657 666 <span type="species:ncbi:1280">S. aureus</span>
###xml 730 739 <span type="species:ncbi:1280">S. aureus</span>
###xml 874 878 <span type="species:ncbi:10116">Rats</span>
S. aureus from a human endophthalmitis sample was cultured in tryptase soy broth. The bacterial suspension was centrifuged, and washed with sterile saline. The suspension was serially diluted with sterile saline to 65 CFU/50 muL. Each rat was anesthetized with an intramuscular injection of 0.125 ml of a 1 : 1 mixture of 100 mg/ml ketamine and 20 mg/ml xylazine; a drop of proparacaine 0.5% was instilled in the right eye of S. aureus inoculated and sham injected rats. Five muL of aqueous humor was aspirated from the experimental eyes to minimize any increase in intraocular pressure with the subsequent inoculation of S. aureus or BSS. The experimental S. aureus group received an intravitreal injection of 50 muL (65 CFU) of S. aureus suspension through the pars plana, and the vehicle-injected group received 50 muL of BSS. Postinjection eyes were irrigated with BSS. Rats were euthanized using phenobarbital at 24 or 48 hours after the injection, and eyes were harvested for immunohistochemical studies.
###end p 11
###begin title 12
2.2. Fixation and processing of tissue for immunohistochemistry
###end title 12
###begin p 13
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 24 33 <span type="species:ncbi:1280">S. aureus</span>
###xml 52 56 <span type="species:ncbi:10116">rats</span>
###xml 110 114 <span type="species:ncbi:10116">rats</span>
###xml 162 166 <span type="species:ncbi:10116">rats</span>
The right eyes from the S. aureus inoculated (eight rats for each time point), vehicle-injected groups (eight rats for each time point), and untreated control (5 rats) groups euthanized at 24 and 48 hours were enucleated for immunohistochemical studies. The eyes were submerged in 10% buffered formalin for 3 days, washed with distilled water, rehydrated through a graded series of ethanol, embedded in paraffin, and processed for immunohistochemistry.
###end p 13
###begin p 14
###xml 204 208 <span type="species:ncbi:9925">goat</span>
###xml 277 281 <span type="species:ncbi:9925">goat</span>
###xml 543 549 <span type="species:ncbi:9986">rabbit</span>
###xml 555 559 <span type="species:ncbi:9925">goat</span>
###xml 853 857 <span type="species:ncbi:9925">goat</span>
Immunohistochemical staining was performed using an avidin-biotin-peroxidase complex technique. Paraffin-embedded sections were treated with 0.6% hydrogen peroxide in methanol and blocked with 10% normal goat serum. Primary antibody consisted of 1 : 100 dilution of polyclonal goat anti-SLPI at 1 : 100 dilution (Santa Cruz Biotechnology, Inc., Santa Cruz, Calif, USA) was applied to the eye sections, incubated at room temperature for 1 hour, and the unbound antibody was removed with TBS (20 mM Tris-HCl pH 7.5, 150 mM NaCl). A biotinylated rabbit anti-goat IgG secondary antibody (Vector Laboratories, Burlingame, Calif, USA) was applied and amplified with avidin-biotin-peroxidase complex (Vector Laboratories, Burlingame, Calif, USA). Signals were developed for visualization with 3,3' diaminobenzidine. Control sections were incubated with normal goat serum. All samples were stained in parallel to minimize specimen variation. Masked pathologists graded the cell staining intensity quantitatively.
###end p 14
###begin title 15
2.3. Western blot analysis
###end title 15
###begin p 16
###xml 75 84 75 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 415 417 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 415 417 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&#956;</italic></italic>
###xml 484 485 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 61 65 <span type="species:ncbi:10116">rats</span>
###xml 75 84 <span type="species:ncbi:1280">S. aureus</span>
###xml 109 113 <span type="species:ncbi:10116">rats</span>
###xml 153 157 <span type="species:ncbi:10116">rats</span>
Vitreous samples were collected from the right eyes of seven rats from the S. aureus inoculated group, seven rats from the vehicle-injected group, and 5 rats from the control group using a 20-gauge needle. Retina tissue was excised under a dissecting microscope by masked pathologist and placed in a sterile tube. Vitreous samples and retina tissue were homogenized separately in phosphate-buffered saline with 100 muM butylated-hydroxytoluene and centrifuged for 10 minutes at 15400 g. The supernatants were stored at -80degreesC.
###end p 16
###begin p 17
###xml 270 279 270 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 260 264 <span type="species:ncbi:10116">rats</span>
###xml 270 279 <span type="species:ncbi:1280">S. aureus</span>
The levels of SLPI from vitreous and retinal samples were assessed by Western blot, with each blot being performed in duplicate. The blot was probed with polyclonal antibody against SLPI used for the immunostaining. For the positive control we used serum from rats with S. aureus sepsis (data not shown). Fifteen microliters of each homogenate were run under either reducing or nonreducing (r, nr) conditions at ambient temperature using a modified Laemmli method. The samples were electrophoresed on 10-15% polyacrylamide SDS gel at 100 volts for 2 hours and transferred to nitrocellulose membranes at 120 volts for 2 hours (Bio-Rad, Richmond, Calif, USA). The nitrocellulose paper was incubated at room temperature in blocking buffer (PBS, 0.05% Tween 20, 0.5% nonfat dry milk) with the primary antibody (1 : 1000 dilution) and the secondary antibody (1 : 2000 dilution) for 1 hour each on a rotating platform. After three washes with TBS-T (TBS, 0.05% Tween-20), the membranes were incubated in enhanced chemiluminescence solution (Amersham Life Science, Arlington Heights, Ill, USA) followed by exposure to film.
###end p 17
###begin p 18
The Western blots from ocular specimens with each one in duplicate were subjected to densitometry analysis (Molecular Dynamics, Sunnyvale, Calif, USA) and normalized to a standard curve to obtain relative SLPI values.
###end p 18
###begin title 19
2.4. Statistical analysis
###end title 19
###begin p 20
###xml 107 116 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 206 207 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 107 116 <span type="species:ncbi:1280">S. aureus</span>
Relative SLPI values were reported as mean +/- standard deviation (SD). Statistical analysis comparing the S. aureus inoculated, vehicle-injected, and control groups was done using the Mann-Whitney test. A P value less than .05 was considered statistically significant.
###end p 20
###begin title 21
3. RESULTS
###end title 21
###begin p 22
###xml 296 305 296 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(a)</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(b)</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(c)</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(d)</xref>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
###xml 296 305 <span type="species:ncbi:1280">S. aureus</span>
We used a murine model to elucidate the role of SLPI, an antimicrobial peptide, in endophthalmitis. Immunohistochemical studies show an initial neutrophilic infiltrate consistent with the inflammatory response evident at histopathology examination. At 24 hours after intraocular inoculation with S. aureus, there was intense SLPI staining in the vitreous and retinal tissues (Figures 1(a)and1(b)). The eyes from the vehicle-injected and untreated control groups did not show clinical signs of inflammation, inflammatory cell infiltrates, or SLPI staining in the vitreous and retina by immunohistochemistry (Figures 1(c)and1(d)). A few samples  from the vehicle-injected and control groups showed weak SLPI staining of retinal vessels (not shown). At 24 hours postinoculation, the anterior segment structures did not manifest histological or immunohistochemical changes.
###end p 22
###begin p 23
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(e)</xref>
###xml 575 583 575 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">and 1(f)</xref>
###xml 50 59 <span type="species:ncbi:1280">S. aureus</span>
Forty-eight hours post inoculation, eyes from the S. aureus inoculated group demonstrated an intense inflammatory reaction at slit lamp examination. In contrast with the eyes 24 hours postinoculation, there was evident inflammation of the anterior segment. The inflammatory infiltrate was more marked with associated tissue necrosis. Immunohistochemically, there was intense and diffuse staining of SLPI in all ocular structures. Positive staining for SLPI in the anterior chamber, corneal epithelium, and stroma corroborated the slit lamp findings of keratitis (Figures 1(e)and 1(f)).
###end p 23
###begin p 24
Eyes in the vehicle-injected and control groups did not reveal inflammatory changes at slit lamp examination or in histopathology studies. When examined for presence of SLPI, none of eyes studied had any discernible immunohistochemical reaction.
###end p 24
###begin p 25
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 203 210 203 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
S. aureus infection with its associated inflammatory response is a major trigger for the increased production of SLPI, not observed in the vehicle-injected or untreated control groups at 24 or 48 hours (Table 1).
###end p 25
###begin p 26
###xml 164 173 164 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(a)</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(b)</xref>
###xml 436 447 436 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2(c)</xref>
###xml 596 607 596 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2(d)</xref>
###xml 164 173 <span type="species:ncbi:1280">S. aureus</span>
###xml 523 527 <span type="species:ncbi:10116">rats</span>
We used Western blots with densitometry to quantify SLPI protein expression in the posterior segment structures. Both the vitreous and retinal homogenates from the S. aureus inoculated group at either 24 or 48 hours post injection had high levels of SLPI specific immunoreactivity by Western blot (Figures 2(a)and2(b)). The vehicle-injected and untreated control groups were void of SLPI expression in the vitreous at both time points (Figure 2(c)). In contrast, retinal homogenates from the vehicle-injected and untreated rats showed slight SLPI expression both at 24 or 48 hours postinjection (Figure 2(d)).
###end p 26
###begin p 27
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&lt;</italic>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
The values of SLPI bands from western blots were quantified by densitometric analysis and subjected to statistical analysis (P< .05 versus control group, Mann-Whitney test) to determine whether there was a difference between the endophthalmitis group and the BSS groups (Table 2).
###end p 27
###begin title 28
4. DISCUSSION
###end title 28
###begin p 29
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
We hypothesized that SLPI plays a role in the innate immune defense of the eye in response to intraocular inflammation and infection. This study is the first to document that SLPI is strongly expressed in inflamed eyes in an animal model of endophthalmitis and that SLPI expression is directly associated with infiltration by inflammatory cells in ocular tissues. Given what is known about the role of SLPI in other tissues such as lung, skin, and placenta [8, 22, 26], our findings suggest that SLPI is secreted in order to promote the early eradication of invading microorganisms and to protect the eye against proteolytic destruction by inflammatory cells.
###end p 29
###begin p 30
###xml 58 67 58 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 58 67 <span type="species:ncbi:1280">S. aureus</span>
We conclude that SLPI expression increases as a result of S. aureus infection and the associated inflammatory response. This is supported by our findings that SLPI expression correlates in location, time, and intensity with the clinical infection. SLPI expression and the inflammatory response colocalize in the posterior segment in inoculated eyes. As the infection progresses to the anterior segment at 48 hours, the SLPI immunoreactivity colocalizes to the cornea. By immunohistochemistry, SLPI is upregulated as the mounted inflammatory response intensifies at 48 hours when compared to the 24-hour time point. Thus, SLPI expression also correlates temporally and in intensity with the infectious process.
###end p 30
###begin p 31
The absence of elevated SLPI expression in the sham-injected eyes argues against the trauma from the injection as the cause of the SLPI response. The correlation of SLPI in place, time, and intensity with the inflammatory process strongly supports that SLPI is upregulated as a result of the infection and/or inflammation. The weak expression of SLPI in retinal homogenates from control and BSS groups in Western blots may be associated with the retinal vessels that stain for SLPI in immunohistochemistry assays and not be related to production by native retinal cells. The presence of SLPI in the retinal vasculature suggests that SLPI is produced by cells recruited from the extracellular matrix (ECM).
###end p 31
###begin p 32
###xml 128 142 128 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus</italic>
###xml 213 222 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 213 222 <span type="species:ncbi:1280">S. aureus</span>
Several microbiological studies describe that the most common pathogens responsible for acute postoperative endophthalmitis are Staphylococcus species, the rationale underlying the choice of a clinical isolate of S. aureus for our study [1, 3]. The consequences of endophthalmitis are dire: delayed diagnosis and treatment of endophthalmitis may produce irreversible inflammatory damage and may consequently lead to loss of vision [1, 4, 13]. The inflammatory chemotactic factors and toxins from bacteria can induce leukocyte infiltration, principally transendothelial migration of neutrophils from the vascular circulation to the ECM [14]. The ECM serves as a structural scaffold of macromolecules and as a reservoir of inflammatory mediators [15]. The balance between ECM formation and destruction associated with inflammatory and infectious processes is maintained by the presence of endogenous tissue inhibitors of proteases [16, 17].
###end p 32
###begin p 33
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 457 462 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 457 462 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&#945;</italic></italic>
###xml 491 492 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 494 496 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 629 630 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 632 633 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 635 637 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 639 641 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 642 644 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
The concept that certain peptides have antiinflammatory properties and contribute to the innate host defense has been reported in other organ systems [18]. Specifically, SLPI is involved in protection against damage from tissue inflammation [9, 12]. It also neutralizes the action of neutrophil elastase as well as other proteases secreted in the ECM [19, 22]. In addition, SLPI is upregulated in response to proinflammatory cytokines, such as IL-1 and TNF-alpha, and to bacterial products [9, 11]. Recent studies demonstrate that the SLPI is secreted by inflammatory and noninflammatory cells in response to tissue destruction [8, 9, 12, 23-26]. In conjunction with our findings, SLPI likely plays a similarly important pathophysiologic role in bacterial endophthalmitis, Most likely, it is expressed in response to inflammation itself, although our data do not directly rule out SLPI expression directly triggered by bacterial toxins or cell wall components.
###end p 33
###begin p 34
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
In conclusion, we demonstrate that SLPI is not produced in ocular tissues under normal physiologic conditions. This peptide may be secreted in order to promote the early eradication of invading microorganisms and to protect the eye against proteolytic destruction by inflammatory cells. Previous experiments shows SLPI expression in bronchial, nasal, and cervical tissues and in tears [19-21]; our study expands upon these findings and highlights the role of SLPI in intraocular inflammation and ocular innate immunity. The known antiprotease and antimicrobial activities of SLPI suggest that its expression is actively regulated at the site of ocular tissue inflammation. Because of its endogenous antimicrobial activities and role as an inflammatory mediator, further studies addressing the role of SLPI in innate ocular immunity and in wound healing may have consequences in the development of innovative prophylactic and therapeutic strategies for eye disease.
###end p 34
###begin article-title 35
A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group
###end article-title 35
###begin article-title 36
###xml 138 145 <span type="species:ncbi:9606">Patient</span>
Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team
###end article-title 36
###begin article-title 37
Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study
###end article-title 37
###begin article-title 38
###xml 19 40 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 62 68 <span type="species:ncbi:9986">rabbit</span>
Immune response to Staphylococcus aureus endophthalmitis in a rabbit model
###end article-title 38
###begin article-title 39
Antibiotic peptides as mediators of innate immunity
###end article-title 39
###begin article-title 40
Defensins and other endogenous peptide antibiotics of vertebrates
###end article-title 40
###begin article-title 41
Defensins: antimicrobial and cytotoxic peptides of mammalian cells
###end article-title 41
###begin article-title 42
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis
###end article-title 42
###begin article-title 43
Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?
###end article-title 43
###begin article-title 44
Antimicrobial activity of antileukoprotease
###end article-title 44
###begin article-title 45
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide
###end article-title 45
###begin article-title 46
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide
###end article-title 46
###begin article-title 47
###xml 40 66 <span type="species:ncbi:1282">Staphylococcus epidermidis</span>
A natural history study of experimental Staphylococcus epidermidis endophthalmitis
###end article-title 47
###begin article-title 48
T cell control of extracellular matrix degradation
###end article-title 48
###begin article-title 49
Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation
###end article-title 49
###begin article-title 50
Matrix metalloproteinases in immunity
###end article-title 50
###begin article-title 51
Recent advances in chemokines and chemokine receptors
###end article-title 51
###begin article-title 52
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse B-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs
###end article-title 52
###begin article-title 53
###xml 59 64 <span type="species:ncbi:9606">human</span>
Structure, genomic organization and tissue distribution of human secretory leukocyte-protease inhibitor (SLPI): a potent inhibitor of neutrophil elastase
###end article-title 53
###begin article-title 54
###xml 82 87 <span type="species:ncbi:9606">women</span>
Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle
###end article-title 54
###begin article-title 55
###xml 92 97 <span type="species:ncbi:9606">human</span>
Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid
###end article-title 55
###begin article-title 56
###xml 110 115 <span type="species:ncbi:9606">human</span>
Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes
###end article-title 56
###begin article-title 57
###xml 56 61 <span type="species:ncbi:9606">human</span>
Secretory leukocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes
###end article-title 57
###begin article-title 58
###xml 56 61 <span type="species:ncbi:9606">human</span>
Production of secretory leukocyte protease inhibitor by human amniotic membranes and regulation of its concentration in amniotic fluid
###end article-title 58
###begin article-title 59
Antibacterial activity of antileukoprotease
###end article-title 59
###begin article-title 60
Antileukoprotease: and endogenous protein in the innate mucosal defense against fungi
###end article-title 60
###begin p 61
Photomicrographs of immunostaining for SLPI at 24 hours in the endophthalmitis group (panels a-b). Note positive retinal SLPI immunostaining, associated with inflammatory cell infiltration and tissue necrosis. No staining was present in vitreous and retinal structures in the normal and BSS groups (panels c-d). Strong expression of SLPI was identified in endophthalmitis samples at 48 hours at vitreous samples as well as corneal tissue (arrows, panels e-f). (Immunohistochemistry, , panels a-b-e, and  magnification panels c-d-f.)
###end p 61
###begin p 62
Representative western blots of SLPI expression of supernatant from the endophthalmitis group (a)-(b) and BSS group (c)-(d) were analyzed. Infection with associated inflammation induces the expression of SLPI (12 kDa) at 48 hours in vitreous (a) and retina (b) homogenates in all infected eyes. There is no expression at 48 hours in vitreous samples from injected BSS group (c). However, a weak basal expression at retinal homogenates was found in BSS and control groups (d). Note the strong level of SLPI in the endophthalmitis group (a), (b).
###end p 62
###begin p 63
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Immunohistochemical detection of secretory leukocyte protease inhibitor in ocular rat samples.
###end p 63
###begin p 64
*Double masked observer determined the total positive immunostained corneas for SLPI in the experimental group. Immunoreactivity is reported as number of positively immunostained eyes/total number of eyes examined in the endophthalmitis group at 24 and 48 hours.
###end p 64
###begin p 65
###xml 45 66 45 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BSS</italic>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&lt;</italic>
###xml 45 66 <span type="species:ncbi:1280">Staphylococcus aureus</span>
**Statistically different when comparing the Staphylococcus aureus or BSS inoculated eye (OD) to normal control eye (OS). (P< .05 using Fisher's exact test analysis.) ns = not statistically significant.
###end p 65
###begin p 66
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Western blot densitometry analysis of secretory leukocyte protease Inhibitor in ocular rat samples.
###end p 66
###begin p 67
*Double masked observer determined the total positive immunoblots for SLPI in the posterior segment eye structures. The immunoblots for SLPI from endophthalmitis and BSS groups were subjected to densitometry analysis.
###end p 67
###begin p 68
###xml 45 66 45 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BSS</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&lt;</italic>
###xml 45 66 <span type="species:ncbi:1280">Staphylococcus aureus</span>
**Statistically different when comparing the Staphylococcus aureus or BSS inoculated eye (OD) to normal control eye (OS). P< .05 using Mann-Whitney test; values are means +/- standard deviation. ns = not statistically significant.
###end p 68

